IMPROVING THE CANCER BATTLE WITH INTEGRATED GENOMICS

| February 6, 2020

article image
The fight against cancer has been boosted tremendously since the discovery of checkpoint inhibitor therapy – a form of cancer immunotherapy where key regulators of the immune system are blocked so that immune cells can attack the tumor. However, the level of patient response to currently approved therapies is quite variable, restricting the chances of success of a checkpoint inhibitor therapy. Not knowing whether a patient will respond to immunotherapy and if there are specific molecular features that can help predict a response is a substantial limitation to immune checkpoint inhibitor drugs.

Spotlight

Integra Health

Integra Health is a health consultancy and think tank operating out of Lagos, Nigeria with a backbone of 11 consultants and 39 full-time healthcare professionals. We work on profitable innovations and solutions that add sustainable value to developing health systems.

OTHER ARTICLES
MEDICAL

Better Purification and Recovery in Bioprocessing

Article | August 2, 2021

In the downstream portion of any bioprocess, one must pick through the dross before one can seize the gold the biotherapeutic that the bioprocess was always meant to generate. Unfortunately, the dross is both voluminous and various. And the biotherapeutic gold, unlike real gold, is corruptible. That is, it can suffer structural damage and activity loss. When discarding the dross and collecting the gold, bioprocessors must be efficient and gentle. They must, to the extent possible, eliminate contaminants and organic debris while ensuring that biotherapeutics avoid aggregation-inducing stresses and retain their integrity during purification and recovery. Anything less compromises purity and reduces yield. To purify and recover biotherapeutics efficiently and gently, bioprocessors must avail themselves of the most appropriate tools and techniques. Here, we talk with several experts about which tools and techniques can help bioprocessors overcome persistent challenges. Some of these experts also touch on new approaches that can help bioprocessors address emerging challenges.

Read More
DIAGNOSTICS

Making Predictions by Digitizing Bioprocessing

Article | April 20, 2021

With advances in data analytics and machine learning, the move from descriptive and diagnostic analytics to predictive and prescriptive analytics and controls—allowing us to better forecast and understand what will happen and thus optimize process outcomes—is not only feasible but inevitable, according to Bonnie Shum, principal engineer, pharma technical innovation, technology & manufacturing sciences and technology at Genentech. “Well-trained artificial intelligence systems can help drive better decision making and how data is analyzed from drug discovery to process development and to manufacturing processes,” she says. Those advances, though, only really matter when they improve the lives of patients. That’s exactly what Shum expects. “The convergence of digital transformation and operational/processing changes will be critical for the facilities of the future and meeting the needs of our patients,” she continues. “Digital solutions may one day provide fully automated bioprocessing, eliminating manual intervention and enabling us to anticipate potential process deviations to prevent process failures, leading to real-time release and thus faster access for patients.” To turn Bioprocessing 4.0 into a production line for precision healthcare, real-time release and quickly manufacturing personalized medicines will be critical. Adding digitization and advanced analytics wherever possible will drive those improvements. In fact, many of these improvements, especially moving from descriptive to predictive bioprocessing, depend on more digitization.

Read More

Spotlight

Integra Health

Integra Health is a health consultancy and think tank operating out of Lagos, Nigeria with a backbone of 11 consultants and 39 full-time healthcare professionals. We work on profitable innovations and solutions that add sustainable value to developing health systems.

Events